A detailed history of New York State Common Retirement Fund transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,522 shares of ALXO stock, worth $23,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,522
Previous 12,522 -0.0%
Holding current value
$23,416
Previous $76,000 69.74%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$5.84 - $17.56 $724 - $2,177
-124 Reduced 0.98%
12,522 $76,000
Q1 2024

May 07, 2024

BUY
$10.95 - $16.79 $1,741 - $2,669
159 Added 1.27%
12,646 $141,000
Q4 2023

Feb 01, 2024

SELL
$4.81 - $15.38 $2,073 - $6,628
-431 Reduced 3.34%
12,487 $186,000
Q3 2023

Nov 07, 2023

BUY
$4.19 - $7.35 $243 - $426
58 Added 0.45%
12,918 $62,000
Q2 2023

Aug 07, 2023

SELL
$4.37 - $9.56 $100 - $219
-23 Reduced 0.18%
12,860 $97,000
Q4 2022

Jan 30, 2023

SELL
$9.51 - $12.95 $104 - $142
-11 Reduced 0.09%
12,883 $145,000
Q3 2022

Nov 08, 2022

BUY
$8.23 - $15.14 $609 - $1,120
74 Added 0.58%
12,894 $123,000
Q2 2022

Aug 04, 2022

SELL
$5.89 - $19.46 $176 - $583
-30 Reduced 0.23%
12,820 $104,000
Q1 2022

May 05, 2022

BUY
$13.65 - $22.06 $177 - $286
13 Added 0.1%
12,850 $217,000
Q4 2021

Feb 02, 2022

SELL
$21.49 - $74.4 $330,129 - $1.14 Million
-15,362 Reduced 54.48%
12,837 $276,000
Q3 2021

Nov 02, 2021

SELL
$52.51 - $80.91 $892 - $1,375
-17 Reduced 0.06%
28,199 $2.08 Million
Q2 2021

Aug 02, 2021

BUY
$52.2 - $75.23 $229,941 - $331,388
4,405 Added 18.5%
28,216 $1.54 Million
Q1 2021

May 11, 2021

BUY
$62.84 - $87.68 $364,472 - $508,544
5,800 Added 32.2%
23,811 $1.76 Million
Q4 2020

Feb 08, 2021

BUY
$34.11 - $112.26 $464,271 - $1.53 Million
13,611 Added 309.34%
18,011 $1.55 Million
Q3 2020

Nov 05, 2020

BUY
$29.36 - $47.1 $129,184 - $207,240
4,400 New
4,400 $166,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $76.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.